Mirion Technologies, Inc. develops and provides radiation detection, measurement, and analysis solutions. Its products and services are used to monitor radiation, support nuclear safety, improve operational efficiency, and provide data for medical, industrial, scientific, and government applications.
The company’s offerings include radiation detectors, spectroscopy systems, dosimetry and personnel-monitoring solutions, radiation-monitoring equipment, and related software and services. In healthcare, Mirion provides technologies used in radiation therapy quality assurance, medical imaging, and radiation safety. Its products also support nuclear power generation, nuclear decommissioning, defense and national security, research laboratories, and other specialized environments.
Mirion serves customers internationally through a portfolio of established radiation-technology businesses and operates across North America, Europe, and other global markets. The company became publicly traded in 2021 following a business combination with a special purpose acquisition company. Mirion is headquartered in the United States and is led by Chief Executive Officer Thomas D. Logan.
AI Generated. May Contain Errors.
